Temodal (Temozolomide) Post Marketing Surveillance Protocol (Study P05557AM2)

Clinical trial NCT00723827 · COMPLETED

Trial details

NCT number: NCT00723827
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Glioblastoma Glioma Astrocytoma

Start date: 2008-03-01
Primary completion: 2011-09-01
Enrollment: 682

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.